Bioadaptives, Inc. (BDPT) Shares Outstanding (2013 - 2026)

Bioadaptives has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $266.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 126.91% year-over-year to $266.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $266.8 million (up 126.91% YoY) and the FY2025 annual result came in at $190.2 million, up 2215.37% from the prior year.
• Shares Outstanding (Entity) improved to $266.8 million in Q1 2026 per BDPT's latest filing, from $190.2 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.2 billion in Q1 2024 and troughed at $8.2 million in Q4 2024.
• A 5-year average of $363.3 million and a median of $190.2 million in 2025 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) plunged 98.53% in 2024, then soared 2215.37% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $106.0 million in 2022, then soared by 427.37% to $559.1 million in 2023, then slumped by 98.53% to $8.2 million in 2024, then jumped by 2215.37% to $190.2 million in 2025, then soared by 40.24% to $266.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $266.8 million, $190.2 million, and $143.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.